Mark Abate in Santa Barbara, California

Home California Santa Barbara

Mark Abate has Hematology/oncology as his primary medical specialty. Their primary office is: 317 W Pueblo St in Santa Barbara, California.

They're a part of the: Sansum Clinic medical group which has around 273 members. You can call their office at 805-681-7500 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Connecticut School Of Medicine and graduated in 1982 (around 42 years of experience). They are listed as doing telehealth appointments.

Mark Abate Office Phone and Directions

Mark Abate
Sansum Clinic
317 W Pueblo St
Santa Barbara, California 93105
805-681-7500

Patient Ratings
Please rate your experience with Mark Abate below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 805-681-7500

Enter a starting address:

Healthcare Info for Mark Abate

Medical School: University Of Connecticut School Of Medicine
Graduation Year: 1982
The Primary Medical Specialty for Mark Abate is listed as: Hematology/oncology
Approximate Years of Experience: 42
PAC (PECOS ID)#: 6901965557
NPI #: 1588778674
NPI Created On: 08/18/2006
NPI Last Updated Listed as: 01/28/2019
Primary Taxonomy Code: 207RH0003X
License Number:
G55892
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Collection of blood specimen from a completely implantable venous access device
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Subsequent hospital inpatient care, typically 25 minutes per day
Physician telephone patient service, 11-20 minutes of medical discussion
Physician telephone patient service, 21-30 minutes of medical discussion
Injection, dexamethasone sodium phosphate, 1 mg
Leuprolide acetate (for depot suspension), 7.5 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433385

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433389

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433393

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433405

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433409

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788433413

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 830919475

Being Disputed:: No

Product Related: No

Payments Total: $126

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783467305

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Hematology/oncology Professionals in Santa Barbara

1.
Thomas Woliver

215 Pesetas Ln
Santa-barbara, CA
Sansum Clinic

2.
Julian Davis

309 W Quinto St
Santa-barbara, CA
The Regents Of The University Of California

3.
Gregg Newman

215 Pesetas Ln
Santa-barbara, CA
Sansum Clinic

4.
Ryan Kendle

317 W Pueblo St
Santa-barbara, CA
Sansum Clinic

5.
Frederick Kass MD

309 W Quinto St
Santa-barbara, CA
The Regents Of The University Of California

6.
Mukul Gupta MD

317 W Pueblo St
Santa-barbara, CA
Sansum Clinic

Providers in Sansum Clinic

1.Mark Abate

317 W Pueblo St
Santa Barbara Ca 93105-4310
Sansum Clinic
Hematology/oncology

2.Justin Abraham

317 W Pueblo St
Santa Barbara Ca 93105-4310
Sansum Clinic
Neurology

3.Natalie Achamallah

301 W Pueblo St
Santa Barbara Ca 93105-4310
Sansum Clinic
Internal Medicine

4.Hosam Ahmad

317 W Pueblo St
Santa Barbara Ca 93105-4310
Sansum Clinic
Internal Medicine

5.Ambareen Ahmed

1919 State St
Santa Barbara Ca 93101-8446
Sansum Clinic
Family Practice

6.Allison Akers

2027 Village Ln
Solvang Ca 93463-2271
Sansum Clinic
Family Practice

View all 273 members of Sansum Clinic medical group